Qingpeng Wang

19PUBLICATIONS
7CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Electrochemical energy storage and conversionBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 04, 2026
Development of Telmisartan Platinum(IV) Complexes for Antimetastatic Therapy: Targeting EMT and Tumor Immunity through Suppressing AT1R.

|Sep 17, 2025
Development of Ciprofibrate Platinum(IV) Nanodrugs as Antimetastatic Agents with COFs as Carriers.

Shuaiqi Feng, Yan Chen, Zhifang Liu

|May 27, 2025
Ketogenic diet attenuates microglia-mediated neuroinflammation by inhibiting NLRP3 inflammasome activation via HDAC3 inhibition to activate mitophagy in experimental autoimmune encephalomyelitis.

Qianye Zhang, Mingxiao Zheng, Wei Sun

|May 26, 2025
Grapefruit Extracellular-Vesicle-Derived Nanodrug Loading Three-Functional Platinum(IV) Conjugates with Enhanced Targeting and TME Modulating Properties.

Yan Chen, Shuaiqi Feng, Lanjie Li

|Jan 13, 2025
Autophagy-targeted Pt(IV) agents: a new horizon in antitumor drug development.

Suying Li, Yan Chen, Shuaiqi Feng

|Sep 18, 2024
Ursodeoxycholic Acid Platinum(IV) Conjugates as Antiproliferative and Antimetastatic Agents: Remodel the Tumor Microenvironment through Suppressing JAK2/STAT3 Signaling.

Yan Chen, Ming Zhang, Zhifang Liu

Pageof 4

Frequent Collaborators

9 joint publications

Ning Zhang

6 joint publications

Min Liu

2 joint publications

Bin Sun

2 joint publications

Bin Sun